In the present study, we synthesized a novel functional analog of GLP-1 conjugated to tetramethyl rhodamine to monitor the internalization of the receptor. Our data show that after being internalized the receptor is sorted to lysosomes. In endosomes, receptor-ligand complex is found to be colocalized with adenylate cyclase. Pharmacological inhibition of endocytosis attenuates GLP-1R-mediated cAMP generation and consequent downstream protein kinase A substrate phosphorylation and glucose-stimulated insulin secretion. Our study underlines a paradigm shift in GLP-1R signaling and trafficking. The receptor ligand complex triggers cAMP generation both in plasma membrane and in endosomes, which has implications for receptor-mediated regulation of insulin secretion.
TYPE 2 DIABETES HAS REACHED epidemic levels globally with increased risk of cardiovascular disorders and early mortality. The pathophysiology of the disease lies in altered glucose homeostasis resulting from insulin resistance in muscle, liver, and adipose tissue and impaired insulin secretion from pancreatic ␤-cells. The hormone glucagon-like peptide-1 (GLP-1) secreted from enteroendocrine cells plays a major role in improving glycemic control (9) . The peptide exerts its effect through its interaction with GLP-1 receptor (GLP-1R), which is present in pancreatic ␤-cells as well as in heart, kidney, lung, gastrointestinal tract, and central and peripheral nerves (2) . GLP-1R activation in pancreatic ␤-cells promotes glucose-stimulated insulin secretion (GSIS) (5), comprising a transient first phase and a long-lasting second phase, both of which are blunted in type 2 diabetic patients (30) . Activation of GLP-1R promotes cAMP signaling in pancreatic ␤-cells; however, the temporal and spatial dynamics of cAMP generation in context of insulin granule exocytosis is incompletely understood.
In the majority of cases, G protein-coupled receptor (GPCR) activation and subsequent cAMP synthesis are accomplished exclusively at the plasma membrane (19) .Immediately after activation, the receptor is desensitized and rapidly undergoes endocytosis, which terminates the signaling from the activated receptors. However, there are several exceptions to this canonical pathway, notable among them being parathyroid hormone receptor (26) , thyroid-stimulating hormone receptor (1) , and sphingosine 1-phosphate receptor (16) , where continuous generation of cAMP is reported even after receptor endocytosis.
The crystal structure of the ligand-bound GLP-1R extracellular domain has provided valuable insights into the mechanism of receptor binding and activation (20, 24) . However, very little information is presently available on the mechanism of GLP-1R internalization and intracellular sorting, especially in the context of the dynamics of cAMP generation and its significance on insulin secretion.
In the present study, we explored the activation and endosomal trafficking of the receptor and its ability to generate cAMP in the process. Our data reveal compartmentalized cAMP generation on GLP-1R activation, which contributes to maintaining insulin granule exocytosis in cultured pancreatic ␤-cells before being sorted to lysosome for degradation.
MATERIALS AND METHODS
Reagents. BRIN-BD11 cells were obtained from European Collection of Cell Cultures (ECACC cat. no. 10033003). RPMI Glutmax, Lipofectamine 2000, penicillin-streptomycin, gentamycin, and sodium pyruvate were purchased from Invitrogen (CA), fetal bovine serum (FBS) was from Hyclone Australia, ␤-mercaptoethanol, Dynasore hydrate, and exendin-4 (Ex-4) were purchased from SigmaAldrich (St. Louis, MO). All other chemicals used in this study were of reagent grade.
CRE luciferase reporter assay. BRIN-BD11 cells were cultured at 37°C with 5% CO 2 in RPMI medium supplemented with 10% heat-inactivated FBS, 1 mM sodium pyruvate, 10 g/ml gentamycin, 100 U/ml penicillin, and 100 g/ml streptomycin. Receptor-mediated signaling was assessed by luciferase reporter assay following the method of Fortin et al. (4a) with modifications. In brief, the cells were grown in a 70-mm dish until they attained 70% confluence. A cAMPresponsive element-luciferase reporter plasmid (CRE 6X-luc), which was a kind gift of Prof. Richard Day (Indiana University), and ␤-galactosidase plasmid were transiently transfected in 1:1 ratio using Lipofectamine following the manufacturer's protocol. Four hours after transfection, cells were transferred to 96-well Cell Bind plates (Corning) at a density of 50,000 cells per well. Twenty-four hours after transfection, cells were treated with and without appropriate GLP-1R agonist in Complete medium for 4 h. The medium was then aspirated, cells were lysed, and luciferase activity was measured using Steadylite plus reagent (PerkinElmer Life and Analytical Science, Waltham, MA). To enable correction for interwell variability of transfection, a ␤-galactosidase assay was performed by addition of 2-nitrophenyl-␤-galactopyranoside (Sigma). After incubation for 30 min at 37°C, substrate cleavage was quantified by measuring optical density at 405 nm, and the corresponding values were used to normalize luciferase activity.
Preparation of GLP-1 tetramethyl rhodamine (GLP-1 TMR).
Peptide synthesis was carried out using 4-methyl-benzhydril amine resin (Midwest Biotech) run on a CSBio336 synthesizer. The following sequence (HAEGTFTSDVSSYLEGQAAKEFIAWLVKGK) was prepared using standard 3-(diethoxy-phosphoryl-oxy)-1,2,3-benzotriazin-4-(3H)-one/diisopropyl ethylamine-activated single couplings. Boc/benzyl amino acids were used except for Boc Lys (Fmoc), which was the first COOH-terminal coupling.
The assembled Boc-protected peptide resin was treated with 5 ml of 20% piperidine-DMF (dimethyl formamide) at room temperature for 5-10 min. The resin was filtered and washed with DMF several times, and then 50 mg NHS-rhodamine (Pierce) in 2-3 ml of DMF was added. The reaction was carried out in the dark for 16 h. The resin was filtered and washed with DMF several times, followed by a DCM (dichloromethane) wash. The modified peptide resin was treated with 50% TFA-DCM followed by neutralization with 5% DIEA-DCM. After a final wash with DCM, the peptide resin was cleaved using 10 ml of liquid hydrogen fluoride (HF) and 1 ml p-cresol scavenger. After 1 h in ice bath, the HF was removed in vacuum, and the residue was suspended in ethyl ether. The solids were filtered and washed with ether, and subsequently the peptide was solubilized with 10 ml of 20% aqueous acetic acid followed by 20 ml of 1% aqueous acetic acid-20% acetonitrile. The combined peptide solution was analyzed by ESI mass spectrum. It was applied to a 21.2 ϫ 250-mm Amberchrom XT20 column. A purification gradient was run using an FPLC instrument at 3 ml/min during monitoring of the UV absorbance at 214 nm (2.0A) and collection of 4-min fractions (buffer A, 0.1% TFA; buffer B, 60% aq acetonitrile, gradient ϭ 30%B to 70%B over 300 min). After analysis of the fractions by HPLC and mass spectrometry, the desired fractions were combined and lyophilized to yield 26 mg. HPLC purity of the purified pool was greater than 90%, and MALDI mass spectral analysis confirmed a molecular mass of 3,680.8 (theoretical mass ϭ 3,684.1).
Time course analysis of receptor-ligand internalization. BRIN-BD11 cells were transfected with GLP-1R-GFP plasmid using Lipofectamine and plated in six-well plates containing 25-mm-diameter glass coverslips. Sixty hours after transfection, cells in coverslips were incubated with GLP-1-TMR (1 M) in 200 l of Krebs-HEPES buffer for 60 min at 4°C in the dark. The cells were then washed in PBS and incubated at 37°C for the desired time period in Complete medium, after which they were fixed in 3% paraformaldehyde, mounted in Vectashield mounting medium (Vector Laboratories), and imaged using a Zeiss LSM 510 META confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany) equipped with krypton-argon laser sources. Pinhole diameter was maintained at 1 airy unit. Image acquisition was carried out using a ϫ63 oil immersion objective lens with 2ϫ optical zoom using the Zenlite 2011 program.
Inhibition of endocytosis: Dynasore treatment. BRIN-BD11 cells were transfected with CRE 6X-luc reporter plasmid and ␤-galactosidase plasmid as previously described. Transfected BRIN-BD11 cells were then pretreated with 80 M Dynasore for 30 min in serum-free medium. After pretreatment, cells were stimulated with 50 nM Ex-4 containing 80 M Dynasore for 20 min. Cells were then washed with PBS, and CRE Luciferase Reporter assay was carried out 4 h after stimulation. Transfected cells without Dynasore pretreatment and stimulated with 50 nM Ex-4 served as a positive control.
For immunofluorescence microscopy, BRIN-BD11 cells were transfected with GLP-1R-GFP plasmid using Lipofectamine and plated in six-well plates containing 25-mm-diameter glass coverslips. Sixty hours after transfection, cells in coverslips were incubated with GLP-1-TMR (1 M) in 200 l of Krebs-HEPES buffer for 60 min at 4°C in the dark. The cells were then washed in PBS and incubated at 37°C for the desired time period in Complete medium, after which they were fixed in 3% paraformaldehyde, mounted in Vectashield mounting medium (Vector Laboratories), and imaged using a Zeiss LSM 510 META confocal laser scanning microscope (Carl Zeiss, Oberkochen, Germany) equipped with krypton-argon laser sources.
Sucrose treatment. BRIN-BD11 cells were transfected with CRE6X-luc reporter plasmid and ␤-galactosidase plasmid as previously described. Immunofluorescence and Bodipy-forskolin labeling. Cells were seeded in coverslips, cultured overnight, and treated with 1 M GLP-1-TMR in 200 l Krebs-HEPES buffer for 60 min at 4°C in the dark. After a PBS wash, cells were incubated with 10 M Bodipyforskolin at 37°C in the dark for the indicated time period. The cells were then washed in PBS, fixed in 3% paraformaldehyde, mounted in Permafluor aqueous mounting medium (Thermo Scientific), and imaged using the Zeiss LSM 510 META confocal laser scanning microscope equipped with krypton-argon laser sources.
Western blotting. BRIN-BD11 cells were pretreated with 80 M Dynasore in serum-free medium for 30 min. After pretreatment, medium was removed, and the cells were stimulated with 50 nM Ex-4 in Complete medium containing 80 M Dynasore for another 30 min. Untreated cells, Dynasore pretreated cells, untreated Ex-4-stimulated cells, and Dynasore-pretreated, Ex-4-stimulated cells were lysed in cell lysis buffer containing protease inhibitor (cat. no. P2714, Sigma) and phosphatase inhibitor (cat. no. 524624 EMD Millipore). Fifty micrograms of of the cell extracts were subjected to Western blot analysis using phospho-PKA substrate antibody (cat. no. 9621, Cell Signaling Technology) following standard procedures. Actin immunoblot served as loading control.
Insulin secretion assay. Insulin secretion studies from BRIN-BD11 cells were carried out following the method of Irwin et al. (8) , with modifications, using a Millipore Rat/Mouse Insulin ELISA kit (cat. no. EZRMI-13K). The cells were seeded in 24-multiwell plates at a density of 1.0 ϫ 10 5 cells/well and cultured overnight in Complete medium. Prior to the insulin release experiment, the cells were pretreated with 1 ml of Krebs-Ringer bicarbonate buffer [115 mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2, 1.2 mM KH2P04, 1.2 mM MgSO4, 10 mM NaHCO3. 0.5% (wt/vol) BSA, pH 7.4] supplemented with 1.1 mM glucose. Glucose-stimulated insulin release was measured in the presence and absence of 1 M Ex-4 for 30 min. To measure the effect of insulin release on Dynasore treatment, 80 M Dynasore hydrate was added to the cells 50 min after initiation of pretreatment with Krebs-Ringer bicarbonate buffer, and the insulin release was measured in the presence of 80 M Dynasore. Ten microliters of cell supernatant was used for the ELISA. The insulin release was measured as nanograms per milliliter per 30 minutes per 10 5 cells.
Localization of the receptor in lysosome. BRIN-BD11 cells were transfected with GLP-1RGFP plasmid using Lipofectamine and plated in six-well plates containing 25-mm-diameter glass coverslips. Sixty hours after transfection, cells in coverslips were incubated with 100 nM Ex-4 in 200 l of Krebs-HEPES buffer for 60 min at 4°C. The cells were then washed in PBS and incubated with 100 nM lysotracker (Invitrogen) at 37°C for 40 and 90 min in Complete medium, after which they were fixed in 3% paraformaldehyde, mounted in Vectashield mounting medium, and imaged using the Zeiss LSM 510 META confocal laser scanning microscope equipped with kryptonargon laser sources. Emission was measured at 500 -550 nm band pass for GFP and 575-615 nm for Lysotracker red. Pinhole diameter was maintained at 1 airy unit. Image acquisition was carried out using a ϫ63 oil immersion objective lens with 2ϫ optical zoom using the Zenlite 2011 program.
Localization studies were also carried out using anti Lamp2 antibody raised in rabbit (cat. no. L0668, Sigma). BRIN-BD11 cells were transfected with GLP-1R-GFP plasmid and cultured in coverslips. sixty hours after transfection, cells were incubated with 100 nM Ex-4 in 200 l of Krebs-HEPES buffer for 60 min at 4°C. The cells were then washed in PBS and incubated at 37°C for 90 min in Complete medium, after which they were fixed in 3% paraformaldehyde for 20 min, permeabilized by treatment with 0.1% Triton X-100, and blocked with 5% BSA. The cells were then treated with anti-Lamp2 antibody (1:100 dilutions). Donkey anti-rabbit IgG coupled to Alexa fluor 488 (cat. no. 11034, Invitrogen) was used as a secondary antibody. The coverslips were mounted in Vectashield (Vector Laboratories) and imaged using the Zeiss LSM 510 META confocal laser scanning microscope equipped with krypton-argon laser sources.
Statistical analysis. The data are presented as means Ϯ SE. Statistical significance (P Ͻ 0.05) was assessed by Student's t-test (unpaired).
RESULTS

GLP-1R after activation is rapidly internalized and trafficked to perinuclear space in cytoplasm.
We used BRIN-BD11 cells, a cell line prepared by electrofusion of rat pancreatic ␤-cells and RINM5F cells (13) , to study GLP-1R activation and trafficking. Immunofluorescence microscopy revealed the presence of the receptor as punctate dots in both plasma membrane and cytoplasm (Fig. 1A inset) . To study the func- tional activity of the receptor, we assessed cAMP generation upon treatment with the GLP-1 paralog Ex-4. Figure 1A shows a dose-dependent increase in CRE-luciferase activity on treatment of BRIN-BD11 cells with Ex-4, which was being attenuated by the specific orthosteric GLP-1R antagonist Jant 4 (17) (Fig. 1B) . To study the mechanism of receptor internalization in detail, we synthesized GLP-1-TMR where the fluorophore is attached to a COOH-terminal Lys 30 residue of GLP-1 (Fig.  1C) . The fluorophore-conjugated ligand appears as punctate dot in cytoplasm after internalization (Fig. 1C inset) and retains its biological activity as revealed by its capacity to generate cAMP in BRIN-BD11 cells (Fig. 1C) . We transfected human GLP-1R-GFP in BRIN-BD11 cells and monitored its internalization on activation by GLP-1 TMR (1 M). Figure 2 provides a detailed internalization profile of receptor-ligand complex. At 0 min, both the receptor (green) and the ligand (red) are localized on the membrane, and the merger (yellow) shows complete association of the receptor and ligand (Fig. 2A) . In 5 min, the receptor-ligand complex is localized in cytoplasm, and the association of the receptor and the ligand is revealed by yellow dots as seen in confocal microscopy. The receptorligand complex remains dispersed in cytoplasm until 30 min (Fig. 2, B-D) . At the 40-min time point, the complex appears sequestered in the perinuclear space (Fig. 2E) and is retained until 120 min (Fig. 2, F-H) .The prolonged retention of the GFP-tagged receptor in the perinuclear space indicates that the receptor is not immediately recycled back to the plasma membrane after initial activation in cultured BRIN-BD 11 cells.
Receptor ligand complex in cytoplasm colocalizes with adenylate cyclase. We next analyzed whether the association of receptor ligand complex in cytoplasm has any functional significance. GLP-1R has been reported to potentiate insulin secretion through generation of cAMP. Since cAMP signaling regulates exocytic dynamics of insulin granules (22), we enquired whether internalized receptor-ligand complex contributes to cAMP generation. We used Bodipy-forskolin to label adenylate cyclase following the method of Calebiro et al. (1) with modifications and studied the colocalization with GLP-1 TMR. In unstimulated BRIN-BD11 cells, Bodipy-forskolin staining revealed the presence of adenylate cyclase in plasma membrane as well as in cytoplasm (Fig. 3A) . A partial colocalization of GLP-1-TMR and Bodipy-forskolin (green) was observed 5 min postinternalization (Fig. 3B) , which became extensive 30 min after internalization of the ligand (Fig. 3C) . The dynamic nature of this association is indicative of a functional relationship between internalized receptor-ligand complex and adenylate cyclase present in endosomes.
Inhibition of endocytosis attenuates GLP-1R-mediated cAMP generation in BRIN-BD11 cells.
To elucidate the significance of association of GLP1receptor-ligand complex with adenylate cyclase in cytoplasm, we conducted pharmacological inhibition of endocytosis and measured cAMP generation as determined by CRE-luciferase activity. We inhibited GLP-1R internalization by treatment with Dynasore hydrate (10), which inhibits GTPase activity of dynamin and blocks endocytosis as a consequence. Figure 4A demonstrates the efficacy of Dynasore hydrate in inhibiting the endocytosis of GLP-1-TMR. Unlike control cells, Dynasore hydrate-treated cells do not show internalized receptor-ligand complex, indicating the complete inhibition of endocytosis of GLP-1 receptor-ligand complex on treatment with the compound. Dynasore hydrate also inhibits GLP-1R-mediated cAMP generation. As Fig. 4B reveals, Dynasore treatment caused a fourfold decrease in cAMP generation upon treatment with Ex-4. Hypertonic treatment with 0.43 M sucrose, which blocked internalization of the receptor, similarly caused a fourfold decrease in GLP-1R-mediated cAMP generation, signifying the contribution of internalized receptor-ligand complex to overall cAMP generation in BRIN-BD11 cells (Fig. 4C) .
Vasquez et al. (25) , through the use of metabolic inhibitors and hypertonic medium, explored internalization of GLP-1R and conjectured on the involvement of membrane-associated clathrin lattices in the process. In a parallel observation, Syme et al. (23) , through RNAi-mediated analysis, reported GLP-1R endocytosis to be caveolin-1 dependent in human embryonic kidney (HEK) as well as in mouse insulinoma (MIN6) cell lines. In our present study, we analyzed the effect of clathrin inhibitor Pitstop2 on GLP-1R internalization and receptormediated cAMP generation. Unlike with the Dynasore hydrate, we noticed a significant alteration of morphology of BRIN-BD11 pancreatic cells on treatment with 10 M Pitstop2, which is the reported half-maximal inhibitory concentration (IC 50 ) of the compound that inhibits clathrin-mediated endocytosis in different cell lines (6, 27) . At 5 M concentration, the compound did not inhibit GLP-1R internalization (Fig.  4D) ; however, there was a diminished increase in Ex-4-mediated generation of cAMP (Fig. 4E) , which needs to be further explored in the context of the effect of clathrin inhibition on GLP-1R activation.
Inhibition of endocytosis alters GLP-1R-mediated phosphorylation of PKA substrates and blunts receptor potentiated GSIS.
GLP-1R-mediated cAMP generation activates PKA, which in turn activates a number of substrates orchestrating several signaling pathways. The common motif for PKA activation is RRXS/T, where serine or threonine is the site of phosphorylation. Since the inhibition of endocytosis blunts GLP-1R-mediated cAMP generation, we analyzed whether PKA substrate phosphorylation is altered with pharmacological intervention of endocytosis. Figure 5A reveals Western blot analysis of BRIN-BD 11 cells treated with Ex-4 in the presence and absence of Dynasore. Dynasore treatment altered the PKA substrate phosphorylation profile, as evidenced by the absence of phosphorylated bands above 150 kDa in the Dynasore-treated sample. As the next step, we analyzed whether inhibition of endocytosis with Dynasore treatment blunts the GLP1R-mediated GSIS. As shown in Fig. 5B , Dynasore treatment enhanced basal insulin secretion but attenuated GLP-1R-mediated GSIS, indicating its specific inhibitory action on GLP-1R-mediated GSIS in BRIN-BD11 pancreatic ␤-cells.
The rationale behind this opposing effect of Dynasore hydrate on basal insulin secretion and GSIS is presently unclear. Min et al. (15) reported that RNAi-mediated ablation of dynamin or the overexpression of dominant negative dynamin mutant Dyn K44/A significantly blunts glucose-stimulated insulin exocytosis; however, the role of specific inhibition of GTPase activity of dynamin on GSIS is yet unknown. Dynasore may affect predocked insulin vesicles and "resting and restless newcomer" insulin granules differently; however, an in-depth study of the effect of the molecule on insulin vesicle translocation and fusion has to be carried out to prove the concept.
GLP-1R-glucose-dependent insulinotropic receptor coagonism in BRIN-BD11 cells impedes GLP-1-TMR-mediated receptor activation and internalization in BRIN-BD11 cells.
In our present study, we explored GLP-1R agonism in the presence of different concentrations of IUB68, an analog of glucose-dependent insulinotropic peptide (GIP). As Fig. 6, A and B, reveals, simultaneous addition of GLP1-TMR and GIP does not give an additive pharmacological response. To explore whether this is a consequence of the cross-talk between the two receptors or is due to the limitation in cellular constituents that generate the signal, we evaluated coagonism with GIP at 100 nM, which as a monoagonist generates a limited amount of cAMP (Fig. 6, B and D) . Our data reveal that in concert with 10 M and 1 M data, coagonism of GLP1 with 100 nM GIP also did not result in an additive pharmacological response as measured by CRE-luciferase activity (Fig. 6C) . This indicates that the phenotype might be due to interaction between two receptors at the physiological level. To explore the mechanism further, we analyzed whether GIPR full agonist IUB68 modulates the internalization of GLP-1R in BRIN-BD11 cells (Fig.  6E) . GLP1-TMR monoagonism, as the figure shows, resulted in binding and internalization of the ligand. However, in the case of GLP-TMR coagonism with GIPR full agonist IUB68 at a concentration of 10 M, internalization of GLP-1-TMR was significantly compromised without any effect of binding of the ligand to the receptor (Fig. 6E) . The data imply that cross-talk between the two receptors affects both the cAMP generation and the internalization of GLP-1R. An in-depth analysis is presently under progress to provide insight into the functional implications of interaction between the two incretin receptors especially in the context of endosomal cAMP generation.
Internalized receptor ligand complex is sorted to lysosomes. We next analyzed the fate of the internalized receptor ligand complex. As revealed in Fig. 7, A and B, GLP1R-GFP, 40 and 90 min after initial activation, showed substantial colocalization with Lysotracker, which serves as a lysosomal marker. Similar results were obtained with Lamp2, which is another lysosomal marker (Fig. 7C) . To our knowledge, our data provide the first evidence of lysosomal sorting of GLP-1R in cultured pancreatic ␤-cells. However, further work is required to analyze the temporal dynamics of GLP-1R degradation at lysosomes in BRIN-BD11 cells.
DISCUSSION
Receptor trafficking after internalization is determined by GPCR-interacting proteins (19) . There are specific GPCRinteracting proteins for recycling and for sorting to lysosomes (11) . The expressions of these GPCR-interacting proteins are cell type specific (12) , which leads to differential postendocytic trafficking of the same GPCR in different cell types or tissues. Endocytosis of GLP-1R was first studied by Widmann et al. (28) , where they reported rapid recycling of the receptor. However, the post-internalization trafficking study was conducted in fibroblasts. Our microscopic observations in BRIN-BD11 pancreatic ␤-cells reveal colocalization of internalized GLP-1R with lysosomal markers. The data are in synchrony with the in vitro studies where GLP-1R is reported to interact with sorting nexin and GASP1, which are known to escort GPCRs to lysosome. Moreover, GLP-1R, unlike many class B GPCRs, does not possess the PDZ ligand necessary for recycling the receptor back to the plasma membrane (Table 1) . We believe that the difference in observation regarding GLP-1R trafficking in fibroblasts and pancreatic ␤-cells is dependent on specific GPCR-interacting proteins present in different cell types. Efforts are ongoing in our laboratory to identify GLP-1R-interacting partners in cultured pancreatic ␤-cells.
The presence of GLP-1R and GIPR in BRIN-BD11 cells provided us an opportunity to investigate the cross-talk between the two receptors at the physiological level. Schelshorn et al. (21) reported lateral allosterism between GLP-1R and GIPR where a BRET increase was observed between the receptors on binding with GLP-1. The phenomenon could be reversed with the addition of GIP. They reported that coexpression of GLP-1R and GIPR in the HEK cell line results in an altered flattened pharmacological response to GLP-1 with a significant change in EC 50 and Hill slope. In our present study, we explored GLP-1R agonism in presence of GIP analog IUB68 and functionally active GLP1-TMR analog. The data imply that cross-talk between the two receptors affects both the activation and the internalization of GLP-1R in physiological context. However, an in-depth analysis regarding internalization of GIPR and incretin receptor interaction with various components of activation and internalization machinery is required to provide the mechanistic details associated with this coagonism phenotype. Merlen et al. (14) first demonstrated glucagon receptormediated adenylate cyclase activation in endosome. The observation was followed by evidence on persistent cAMP signaling triggered by internalized thyroid hormone receptor and 
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parathyroid hormone receptor (PTHR) (1, 4) . While this paper was under revision, Irannejad et al. reported ␤ 2 -adrenergic receptor signaling from early endosomes through the use of conformational biosensors (7) . However, the precise mechanism of initiation and attenuation of endogenous cAMP generation by GPCRs is incompletely understood at the present time. In the case of PTHR, binding to ␤-arrestin-1 has been reported to prolong rather than attenuate cAMP generation (3). GLP-1R is known to undergo homologous and heterologous desensitization on binding to the orthosteric ligand (29) . The process is initiated with the phosphorylation of serine residues at its COOH-terminal tail followed by subsequent ␤-arrestinmediated internalization of the receptor (18) . However, it is not known whether ␤-arrestin binding to GLP-1R fosters endogenous cAMP generation or the receptor has to be resensitized to participate in the process. The mechanism by which GLP-1R-mediated endogenous cAMP generation is attenuated is also unknown. In the case of PTHR, cAMP generation by internalized receptors is terminated by retromer complex (3). Similar mechanism of attenuation of endogenous cAMP generation may exist in the case of internalized GLP1R as well. Our colocalization data with Bodipy-forskolin reveal a temporal association of endocytosed receptor ligand complex with adenylate cyclase. Association of adenylate cyclase with the internalized receptor-ligand complex appears to have physiological significance. The pharmacological inhibition of endocytosis decreased total cAMP generation and caused alteration in phosphorylation of PKA substrates and decreased GLP1R-potentiated GSIS. Our observation points toward a novel mechanism (Fig. 8) that reconciles the previous concept on GLP-1R internalization with our current data of endosomal cAMP synthesis and lysosomal sorting of the receptors. However, the present study on the mechanism of internalization of GLP-1R and its role in endosomal cAMP generation to promote GSIS is limited in the context of BRIN-BD11 cells. Further studies are required for the extension of the concept to the other pancreatic ␤-cell lines. Additional studies are also required to explore the dynamic nature of endosomal compartments and its interaction with intracellular trafficking partners, which may provide new mechanistic insights into trafficking and the tissue-specific function of GLP1R.
In summary, our data show that GLP-1R activation in the BRIN-BD11 pancreatic ␤-cell line results in a complex interplay of temporal and spatial cAMP generation that has implications for pancreatic ␤-cell function. Our results reveal that signaling at the surface and additionally within the cell work in tandem to regulate a complex biological phenomenon such as insulin secretion.
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